Fund Evaluator:
Invesco Health Care R6 (GGHSX)
Follow This Fund
Best Performing in Health Over the Last Year
| 62.8% | Fidelity Advisor Biotechnology Z (FIJYX) |
| 62.6% | Fidelity Advisor Biotechnology I (FBTIX) |
| 56.2% | Eventide Healthcare & Life Sciences N (ETNHX) |
| 53.5% | Fidelity Select Biotechnology (FBIOX) |
| 49.5% | Fidelity Select Pharmaceuticals Port (FPHAX) |
Fund Details
Invesco Health Care R6 Overview
Invesco Health Care R6 (GGHSX) is an actively managed Sector Equity Health fund. Invesco launched the fund in 2017.
The investment seeks long-term growth of capital. The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities. It invests primarily in equity securities, including common and preferred stock, and depositary receipts. The fund may invest in the securities of issuers of all capitalization sizes and may invest a significant amount of its net assets in the securities of small- and mid-capitalization issuers.
About Invesco Health Care R6 (GGHSX)
There are 2 members of the management team with an average tenure of 3.02 years: Justin Livengood (2020), Joy Budzinski (2026). Management tenure is more important for actively managed funds than passive index funds.
The fund has 2 primary benchmarks: MSCI World NR USD index with a weighting of 100% and S&P 1500 Health Care TR index with a weighting of 100%. Invesco Health Care R6 has 80 securities in its portfolio. The top 10 holdings constitute 46.7% of the fund’s assets. The fund meets the SEC requirement of being classified as a diversified fund. The fund is not considered to have an ESG focus with its investment selection and management.
Invesco Health Care R6 is part of the Equity global asset class and is within the Sector Equity fund group. Invesco Health Care R6 has 7.8% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 90.0%. There is 7.8% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). Invesco Health Care R6 has 2.3% of the portfolio in cash.
Assets Under Management
The fund has $1 million in total assets, which is below the $884 million average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
GGHSX Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The Invesco Health Care R6 expense ratio is above average compared to funds in the Health category. Invesco Health Care R6 has an expense ratio of 0.72%, which is 41% lower than its category average, making the fund expense ratio grade a A. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. Invesco Health Care R6 has a portfolio turnover rate of 59%, indicating that holds its assets around 0.0 years. By way of comparison, the average portfolio turnover is 61% for the Health category.
Recently, in the month of July 2026, Invesco Health Care R6 returned -1.8%, which earned it a grade of F, as the Health category had an average return of -0.4%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all funds in that category.
Invesco Health Care R6 has a trailing yield of 0.00%, which is below the 0.39% category average. The fund normally distributes its income annually and its capital gains annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
Invesco Health Care R6 Grades
Year to date, the fund has returned 2.1%, 5.0 percentage points worse than the category, which translates into a grade of F. The fund has returned 17.5% over the past year (grade of F), 7.9% over the past three years (grade of D) and 2.8% per year over the past five years (grade of D) and 7.3% per year over the past 10 years (grade of F).
For more mutual fund grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about Invesco Health Care R6, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
GGHSX Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| GGHSX Return (NAV) | -1.8% | 9.0% | 17.5% | 7.9% | 2.8% | 7.3% |
| GGHSX Grade | F | D | F | D | D | F |
| +/- Category | -1.4% | -1.7% | -16.3% | -2.8% | -2.2% | -2.0% |
| Health Avg | -0.4% | 10.7% | 33.9% | 10.7% | 5.0% | 9.3% |
| GGHSX Tax Cost Ratio | na | na | 1.2% | 0.8% | 1.4% | na |
GGHSX Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| GGHSX Return (NAV) | 2.1% | 15.9% | 4.3% | 3.4% | -13.2% | 12.6% | 14.8% | 32.4% | 0.8% | 15.7% | -11.7% |
| GGHSX Grade | F | C | B | D | D | B | D | B | C | F | D |
| +/- Category | -5.0% | -4.7% | 1.8% | -2.1% | -3.8% | 3.8% | -9.7% | 4.0% | 0.4% | -7.7% | -0.8% |
| Health Avg | 7.1% | 20.6% | 2.5% | 5.6% | -9.4% | 8.7% | 24.5% | 28.4% | 0.4% | 23.4% | -10.9% |
| Risk Measures | |
| Standard Deviation: | 14.1% |
| Total Risk Index: | 1.15 - Above Average |
| Category Risk Index: | 0.88 - Below Average |
| Category Risk Grade: | B (32% Rank) |
| Beta: | 0.56 |
| R-Squared: | 25% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Blend |
| Bond Investment Style: | na |
| Yield: | 0.0% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $1207 Mil |
| Fund Total Assets: | $ 2 Mil |
| Share Class Type: | Retirement |
| Portfolio Turnover: | 59% |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 5.6 years | |||
| Average Tenure: 3.0 years | |||
| Managers (Year): Livengood Justin (2020), Budzinski Joy (2026) | |||
Portfolio Composition (as of 6/30/26)
| # of Holdings: | 80 |
| % in Top 10 Holdings: | 46.7% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 7.8% |
Portfolio Allocation |
|
| Domestic Stock: | 90.0% |
| Foreign Stock: | 7.8% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 2.3% |
Purchase Information
| Fund Family: | Invesco |
| Phone Number: | 800-959-4246 |
| Website: | www.invesco.com |
| Status: | Open |
| Inception Date: | April 4, 2017 |
| Min. Initial Purchase: | $1,000,000 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.72% ( Rating : Above Avg ) |
| Category Average Expense Ratio (%): | 1.21% |
| Share Class: | Invesco Health Care A |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
